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Mycobacterium tuberculosis Beijing strains are prevalent in many parts of the world and often give rise to
large institutional outbreaks. Such highly transmissible strains, often associated with multidrug resistance, are
likely underrepresented in outbreaks reported from developing countries, mainly due to nonavailability of fast
detection methods suitable in epidemiological surveillance studies. We evaluated a PCR assay based on
amplification of mycobacterial interspersed repetitive unit locus 26 as a stand-alone method for unambiguous
identification of Beijing strains. The method was used on blinded samples from 10 standard strains whose
Beijing status was already confirmed by spoligotyping. All 10 strains were accurately identified, and their
profiles were corroborated successfully with spoligotypes. The method was also applied to 70 different non-
Beijing clinical isolates from different countries to allow discrimination of isolates. Owing to its accuracy,
simplicity, and rapidity, the assay can be employed in laboratory-level testing of isolates linked to certain
outbreaks. The test can also be adopted for direct application on clinical samples to save time on culturing
bacilli for genotyping.
In 1995, a large section of the Mycobacterium tuberculosis
patient isolates in Beijing, China, was reported to have shared
multicopy IS6110 restriction fragment length polymorphism
patterns. These strains were named “Beijing” strains (15).
Soon it was realized that they are also present in many other
populations irrespective of geographic boundaries (3, 5, 10).
M. tuberculosis strains of Beijing family are linked to tubercu-
losis-related mortality in different parts of the world, some-
times involving clones with multiple drug resistance. Because
Beijing strains are a widespread family of strains, often with
links to multidrug resistance, there are concerns that these
strains might be spreading rapidly due to increased global
travel and the human immunodeficiency virus pandemic.
Rapid identification of such clones is always an urgent need in
case of large outbreaks, particularly those compounded with
human immunodeficiency virus infection and/or nosocomial
spreads. Such strains have an insertion of IS6110 in the
genomic dnaA-dnaN locus (8). All Beijing family strains carry
a characteristic spoligotype that appears to be specific for this
family (7, 14). Spoligotyping reflects genotypic diversity in the
direct repeat region, and “Beijing” spoligotypes only contain
the last nine spacers (from 35 to 43). Spoligotyping has so far
been the “gold standard” for genotypic identification of Beijing
strains. This technique, however, is not very straightforward
and is technically complicated and time consuming, besides
having some interpretation problems (4). We describe a simple
one-step PCR-based rapid detection method for accurate de-
tection of Beijing strains. This PCR method specifically ampli-
fies seven copies of the 51-bp consensus motif at mycobacterial
interspersed repetitive unit (MIRU) locus 26 in the M. tuber-
culosis genome to give a characteristic PCR product of 641 bp.
The MIRU locus 26 coordinate in the M. tuberculosis H37
Rv chromosome is between 2996001 and 2996165 (12). For
PCR amplification of this region, flanking primers (5 TAGG
TCTACCGTCGAAATCTGTGAC 3 and 5 CATAGGCGA
CCAGGCGAATAG 3) were designed essentially as de-
scribed earlier (13). Genomic DNA from 10 known strains of
a confirmed Beijing spoligotype were used to amplify seven
alleles at MIRU locus 26. About 70 clinical M. tuberculosis
isolates belonging to a non-Beijing spoligotype were also geno-
typed with MIRU locus 26. A 25-l PCR mixture contained
about 5 ng of genomic DNA; 0.2 U of AmpliTaq DNA poly-
merase (Applied Biosystems, Foster City, Calif.); 5.0% di-
methyl sulfoxide, 10% (10 mg/ml) bovine serum albumin; 0.2
mM (each) dATP, dCTP, dGTP, and dTTP (Amersham Phar-
macia Biotech Inc., Little Chalfont, United Kingdom); 1.0
PCR buffer (Applied Biosystems); 0.4 M (each) primer; and
2.5 M MgCl2. The thermal cycling reactions were carried out
starting with a denaturing step of 15 min at 95°C, followed by
35 cycles of 1 min at 94°C, 1 min at 59°C, and 1.30 min at 72°C.
The reactions were terminated by incubation for 10 min at
72°C. Negative controls consisting of PCR mixtures lacking
mycobacterial DNA were used. The amplicons were size sep-
arated on 2% agarose gel and visualized by ethidium bromide
staining. The number of repeats at each locus was calculated as
described earlier (13). All the PCR products were confirmed
by DNA sequencing of locus 26 to verify the MIRU copy
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number in each case. To rule out PCR-generated contamina-
tion, we retested the samples and routinely included positive
and negative controls during extractions, PCR mixture prepa-
ration, and electrophoresis. Separate laboratory spaces were
dedicated for the processes of DNA extraction, PCR mixture
preparation, and cycling to rule out the problem of artifactual
contamination.
The M. tuberculosis MIRU 26 locus was found to be a highly
specific, robust, and reproducible PCR target for epidemiolog-
ical screening. We have used eight known strains of M. tuber-
culosis Beijing from the Kremer family of strains (7), and two
strains were obtained from Libya. Spoligotypes for these
strains were obtained from an online database, Ampli-
BASE-MT (http://www.cdfd.org.in/amplibase) (9). A blinded
set of all these samples, including 70 non-Beijing strains, were
tested with MIRU locus 26 PCR, and the results were de-
coded. All the Beijing genotypes were accurately identified
with 100% specificity (Fig. 1). PCR results for all the test
samples were extrapolated to spoligotype patterns with 100%
concordance (Fig. 2). All 70 non-Beijing control samples could
not amplify a product size equivalent to seven copies of MIRU
26. A non-Beijing control strain with a spoligotype nearly sim-
ilar (but not identical) to those of Beijing strains also failed to
amplify a product equal or nearly equal to 642 bp, thus proving
the accuracy of our PCR method (Fig. 2).
Therapeutic regimens for the control of the tuberculosis
epidemic will greatly benefit from knowledge gained from the
molecular epidemiology, geographic genomics, and transmis-
sion dynamics of the pathogen (1, 2, 9, 11). A rapid and cate-
gorical method to determine the pathogen genotypes and ag-
gressiveness of the circulating strains will be the key to the
success of such programs. Multiple-drug-resistant strains can
be highly disseminating, and therefore epidemic control with
treatment strategies such as directly observed therapy short
course becomes problematic. Strains such as Beijing have a
particular propensity for acquiring drug resistance. Recently,
the prevalence of the Beijing family of strains in the world has
been extensively reviewed (6). However, there are no reports
from many African, Latin American, and Asian countries, par-
ticularly India, where a lot of Beijing strains are feared to be
circulating in cities like Delhi and Hyderabad (N. Ahmed et al.,
unpublished observations). This is mainly due to the nonavail-
ability of rapid tests for routine screening purposes. Many
laboratories in such countries are not sufficiently equipped for
spoligotyping or do not have trained personnel. The present
protocol, on the basis of its simplicity, specificity, and sensitiv-
ity, could provide an alternative genotypic method available to
clinical microbiologists in resource-poor countries. Given the
technical complexity of the spoligotyping method and obvious
disadvantages linked to IS6110 typing (13), the MIRU locus 26
signature-based method appears to be suitable for laboratories
involved in diagnostic and epidemiological screening on a rou-
tine basis.
The MIRU variable number tandem repeat (VNTR) mark-
ers (21 polymorphic loci in the genome) as such are quite
robust and resolvable, due to the millions of different allelic
combinations they offer for strain discrimination and typing.
This PCR method can be used directly on total DNA obtained
from patient samples such as peripheral blood, sputa, biopsies,
and lavages (rather than waiting for the cultures to grow), thus
obviating the need for biological containment laboratories for
handling live cultures. While it is tempting to propose clinical
laboratories to adapt this method on sputum samples for rapid
identification of Beijing genotypes circulating in different geo-
graphic areas, further validation and confirmation of this test
with a large number of known Beijing strains would be re-
quired to ensure that all the Beijing strains stably carry seven
copies in MIRU locus 26. Also it will be essential to determine
the molecular clock of such loci and ascertain their stability by
using serial patient isolates obtained over the years. Nonethe-
less, this rapid diagnosis method may be used preliminarily to
initiate any special precautionary treatments until spoligotyp-
ing can be performed.
FIG. 1. PCR-based rapid identification of M. tuberculosis Beijing strains. Lanes show M. tuberculosis genotyping with the MIRU 26 Beijing
isolates and non-Beijing isolates as follows. MIRU 26 Beijing isolates: copy number 7, lanes 4 and 7, Kremer 20 and 44, respectively, and lane 16,
Libya LS35. Non-Beijing isolates: copy no. 6, lane 6, Kremer 98; copy no. 5, lanes 1, 2, 3, and 9, Kremer 120, 121, 12, and 95, respectively, and
lanes 11 and 14, LS2 and LS7, respectively; copy no. 4, lanes 5 and 15, Kremer 82 and LS14, respectively; copy no. 3, lanes 10 and 12, Kremer 41
and 118, respectively; and copy no. 2, lanes 8 and 13, Kremer 97 and 15, respectively. Lane M, 100-bp marker (MBI Fermentas). The table on the
right gives the predicted size of the MIRU 26 PCR product corresponding to the number of alleles. MIRU locus 26 copy numbers are given as
per the conventions described in reference 13.
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FIG. 2. Genotypic and other characteristics of M. tuberculosis. Spoligotypes are from the AmpliBASE MT database (K. Kremer and L.
Sechi).
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